Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Robert Smith's research has focused on multiple areas, including the assessment of genotoxic potential and the development of methods for detecting chromosomal damage. He has investigated the in vivo genotoxic potential of smoke flavoring product mixtures and compared the efficacy of different concentrations for detecting chromosomal damage in vitro and in vivo. Smith also contributed to studies on malaria, specifically examining the impact of RH5 vaccination on blood-stage malaria growth and immune responses in humans.
His work also extends to multiple myeloma, with recent publications detailing long-term follow-up of patients from phase 3 clinical trials, including Total Therapy IV and earlier Total Therapy protocols. Smith has collaborated with researchers such as Guido Tricot, John D. Shaughnessy, Eric R. Siegel, and Clyde Bailey at the University of Arkansas for Medical Sciences on these studies. His scholarship metrics include an h-index of 19, 50 total publications, and 1,390 total citations.
Metrics
- h-index: 19
- Publications: 50
- Citations: 1,390
Selected Publications
-
Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols (2025)
-
Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma (2024)
Collaboration Network
Top Collaborators
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
- Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma
- Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
- Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
- Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
Similar Researchers
Based on overlapping research topics